Gene · 871
Papers3,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,090
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. | Adv Drug Deliv Rev | 2021 | 34139255 | PubTator, text mining | PubMed |
| Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α. | Cancer Sci | 2021 | 34109710 | PubTator, text mining | PubMed |
| Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models. | ERJ Open Res | 2021 | 34109242 | PubTator, text mining | PubMed |
| Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2). | Front Cardiovasc Med | 2021 | 34109226 | PubTator, text mining | PubMed |
| H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis. | J Ovarian Res | 2021 | 34108034 | PubTator, text mining | PubMed |
| Mechanism of collagen folding propagation studied by Molecular Dynamics simulations. | PLoS Comput Biol | 2021 | 34101748 | PubTator, text mining | PubMed |
| Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes. | BMC Cancer | 2021 | 34098875 | PubTator, text mining | PubMed |
| Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD). | Methods Mol Biol | 2021 | 34096005 | PubTator, text mining | PubMed |
| Collagen Biosynthesis, Processing, and Maturation in Lung Ageing. | Front Med (Lausanne) | 2021 | 34095157 | PubTator, text mining | PubMed |
| Omics Profiling of S2P Mutant Fibroblasts as a Mean to Unravel the Pathomechanism and Molecular Signatures of X-Linked MBTPS2 Osteogenesis Imperfecta. | Front Genet | 2021 | 34093655 | PubTator, text mining | PubMed |
| Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era. | BMC Med Genomics | 2021 | 34092239 | PubTator, text mining | PubMed |
| A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. | Sci Rep | 2021 | 34088912 | PubTator, text mining | PubMed |
| Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ. | J Biol Chem | 2021 | 34081964 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Glycoproteomics and Prostate Cancer. | Int J Mol Sci | 2021 | 34069262 | PubTator, text mining | PubMed |
| Current Overview of Osteogenesis Imperfecta. | Medicina (Kaunas) | 2021 | 34068551 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies? | Int J Mol Sci | 2021 | 34065331 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness. | Int J Mol Sci | 2021 | 34065317 | PubTator, text mining | PubMed |
| The Function of KDEL Receptors as UPR Genes in Disease. | Int J Mol Sci | 2021 | 34063979 | PubTator, text mining | PubMed |
| Detection of a Recurrent TMEM38B Gene Deletion Associated with Recessive Osteogenesis Imperfecta. | Discoveries (Craiova) | 2021 | 34036147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/871/papers?page=50